![Robert Michael](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Michael
Director Ejecutivo en ABBVIE INC. .
Fortuna: 17 M $ al 30/06/2024
Cargos activos de Robert Michael
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ABBVIE INC. | Director/Miembro de la Junta | 01/07/2024 | - |
Director Ejecutivo | 01/07/2024 | - | |
Comptroller/Controller/Auditor | 01/03/2017 | 19/10/2018 | |
Director de Operaciones | 29/06/2023 | 01/07/2024 | |
Director Financiero/CFO | 19/10/2018 | 23/06/2022 | |
Corporate Officer/Principal | 01/01/2012 | 01/01/2013 | |
Presidente | 23/06/2022 | 01/07/2024 | |
Treasurer | 01/01/2015 | 01/01/2016 | |
ALLERGAN PLC | Director/Miembro de la Junta | 08/05/2020 | - |
Presidente | 08/05/2020 | - | |
TOBIRA THERAPEUTICS INC | Director Ejecutivo | - | - |
AbbVie Biotherapeutics Ltd.
![]() AbbVie Biotherapeutics Ltd. Financial ConglomeratesFinance Founded in 2016, AbbVie Biotherapeutics Ltd. is a British company that functions as an investment holding company. Part of AbbVie, Inc., the company is based in Maidenhead, UK. | Director/Miembro de la Junta | 01/04/2019 | - |
Fremont Holding LLC
![]() Fremont Holding LLC Pharmaceuticals: MajorHealth Technology Fremont Holding LLC engages in provision of pharmaceutical services. The company is headquartered in North Chicago, IL. | Director Ejecutivo | - | - |
Allergan GI Corp.
![]() Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Director/Miembro de la Junta | - | - |
Presidente | - | - | |
AbbVie Ltd. (United Kingdom)
![]() AbbVie Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie Ltd. (United Kingdom) is a British company that develops advanced therapies through research and innovation. The company is based in Maidenhead, UK and was founded in 2012. | Director de Operaciones | 01/01/2022 | - |
Presidente | 01/01/2022 | - |
Historial de carrera de Robert Michael
Antiguos cargos conocidos de Robert Michael.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ABBOTT LABORATORIES | Corporate Officer/Principal | 01/02/1993 | 01/08/2012 |
Formación de Robert Michael.
Kelley School of Business | Undergraduate Degree |
UCLA Anderson School of Management | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 9 |
Reino Unido | 3 |
Operativa
President | 4 |
Director/Board Member | 4 |
Chief Executive Officer | 3 |
Sectorial
Health Technology | 7 |
Consumer Services | 3 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ABBVIE INC. | Health Technology |
ABBOTT LABORATORIES | Health Technology |
Empresas privadas | 6 |
---|---|
AbbVie Biotherapeutics Ltd.
![]() AbbVie Biotherapeutics Ltd. Financial ConglomeratesFinance Founded in 2016, AbbVie Biotherapeutics Ltd. is a British company that functions as an investment holding company. Part of AbbVie, Inc., the company is based in Maidenhead, UK. | Finance |
Fremont Holding LLC
![]() Fremont Holding LLC Pharmaceuticals: MajorHealth Technology Fremont Holding LLC engages in provision of pharmaceutical services. The company is headquartered in North Chicago, IL. | Health Technology |
Allergan Ltd. (Ireland)
![]() Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Tobira Therapeutics, Inc.
![]() Tobira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on September 11, 2006 and is headquartered in Madison, NJ. | Health Technology |
Allergan GI Corp.
![]() Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Health Technology |
AbbVie Ltd. (United Kingdom)
![]() AbbVie Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie Ltd. (United Kingdom) is a British company that develops advanced therapies through research and innovation. The company is based in Maidenhead, UK and was founded in 2012. | Commercial Services |
- Bolsa de valores
- Insiders
- Robert Michael
- Experiencia